PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development.
Lau HH, Krentz NAJ, Abaitua F, Perez-Alcantara M, Chan JW, Ajeian J, Ghosh S, Lee Y, Yang J, Thaman S, et al. Nat Commun. 2023 Sep 30; 14(1):6119. Epub 2023 Sep 30.